Publications
Advancing knowledge in chronic liver disease through evidence-based research.
AbstractsPublication policy

Showing 10 of 269 papers

Albumin reprograms the B cell transcriptional landscape and improves neutrophil antimicrobial function in patients with decompensated cirrhosis

Clària J, Aguilar F, Lozano JJ, Jiménez Gracia L, Nieto JC, Romero-Grimaldo B, Marcos-Fa X, Giarracco E, Weiss E, Trebicka J, Hernàndez I, Fernández J, Casulleras M, López-Vicario C, Muldur S, Hopke A, Vlagea A, Aransay AM, Marchese D, Bernardi M, Jalan R, Angeli P, Magri G, Cerutti A, Irimia D, Heyn H, Arroyo V, Moreau R.

JHEP Reports, 6(11): 101184

DOI: 10.1016/j.jhepr.2024.101184

Decompensated MASH-cirrhosis model by acute and toxic effects of phenobarbital

Kraus N, Uschner FE, Moeslein M, Schierwagen R, Gu W, Brol MJ, Fürst E, Grünewald I, Lotersztajn S, Rautou PE, Duran-Güell M, Flores Costa R, Clària J, Trebicka J, Klein S; DECISION.

Cells 2024, 13(20): 1707

DOI: 10.3390/cells13201707

State of the art and the future of microbiome-based biomarkers: A multidisciplinary Delphi consensus

Rodriguez J, Hassani Z, Alves Costa Silva C, Betsou F, Carraturo F, Fasano A, Israelsen M, Iyappan A, Krag A, Metwaly A, Schierwagen R, Trebicka J, Zwart H, Doré J, Cordaillat-Simmons M, Druart C.

Lancet Microbe 2024: 100948

DOI: 10.1016/j.lanmic.2024.07.011

Bridging the critically ill patient with acute to chronic liver failure to liver transplantation

Fernández J, Blasi A, Hidalgo E, Karvellas CJ.

Am J Transplant 2024, 24(8): 1348–1361

DOI: 10.1016/j.ajt.2024.03.026

A robust clustering strategy for stratification unveils unique patient subgroups in acutely decompensated cirrhosis

Palomino-Echeverria S, Huergo E, Ortega-Legarreta A, Uson Raposo EM, Aguilar F, Peña-Ramirez C, López-Vicario C, Alessandria C, Laleman W, Queiroz Farias A, Moreau R, Fernandez J, Arroyo V, Caraceni P, Lagani V, Sánchez-Garrido C, Clària J, Tegner J, Trebicka J, Kiani NA, Planell N, Rautou PE, Gomez-Cabrero D.

J Transl Med 2024, 22(1): 599

DOI: 10.1186/s12967-024-05386-2

Acute liver failure: A practical update

Fernández J, Bassegoda O, Toapanta D, Bernal W.

JHEP Rep 2024, 6(9): 101131

DOI: 10.1016/j.jhepr.2024.101131

Distinct immunometabolic signatures in circulating immune cells define disease outcome in acute-on-chronic liver failure

Feio-Azevedo R, Boesch M, Radenkovic S, van Melkebeke L, Smets L, Wallays M, Boeckx B, Philips G, Prata de Oliveira J, Ghorbani M, Laleman W, Meersseman P, Wilmer A, Cassiman D, van Malenstein H, Triantafyllou E, Sánchez C, Aguilar F, Nevens F, Verbeek J, Moreau R, Arroyo V, Denadai Souza A, Clària J, Lambrechts D, Ghesquière B, Korf H, van der Merwe S.

Hepatology 2024

DOI: 0.1097/HEP.0000000000000907

Clinical, experimental and pathophysiological effects of Yaq-001: A non-absorbable, gut-restricted adsorbent in models and patients with cirrhosis

Liu J, MacNaughtan J, Kerbert AJC, Portlock T, Martínez Gonzalez J, Jin Y, Clasen F, Habtesion A, Ji H, Jin Q, Phillips A, De Chiara F, Ingavle G, Jimenez C, Zaccherini G, Husi K, Rodriguez Gandia MA, Cordero P, Soeda J, McConaghy L, Oben J, Church K, Li JV, Wu H, Jalan A, Gines P, Solà E, Eaton S, Morgan C, Kowalski M, Green D, Gander A, Edwards LA, Cox IJ, Cortez-Pinto H, Avery T, Wiest R, Durand F, Caraceni P, Elosua R, Vila J, Pavesi M, Arroyo V, Davies N, Mookerjee RP, Vargas V, Sandeman S, Mehta G, Shoaie S, Marchesi J, Albillos A, Andreola F, Jalan R.

Gut 2024

DOI: 10.1136/gutjnl-2023-330699

Prognosis algorithms for acute decompensation of cirrhosis and ACLF

Valainathan SR, Xie Q, Arroyo V, Rautou PE.

Liver Int 2024

DOI: 10.1111/liv.15927

Recent advances in the prevention and treatment of decompensated cirrhosis and acute-on-chronic liver failure (ACLF) and the role of biomarkers

Trebicka J, Hernaez R, Shawcross DL, Gerbes AL.

Gut 2024

DOI: 10.1136/gutjnl-2023-330584